Results 191 to 200 of about 265,621 (217)

Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells

International Journal of Cancer, 2006
Christian Parr, Wen G Jiang
exaly  

Hay Ventilation

Science, 1940
openaire   +2 more sources

Hepatocyte growth factor activator inhibitors (HAI‐1 and HAI‐2): Emerging key players in epithelial integrity and cancer

Pathology International, 2018
Hiroaki Kataoka, Makiko Kawaguchi, Tsuyoshi Fukushima   +2 more
exaly  

HAI‐2 stabilizes, inhibits and regulates SEA‐cleavage‐dependent secretory transport of matriptase

Traffic, 2017
Annika W Nonboe, Oliver Krigslund, Christoffer Soendergaard   +2 more
exaly  

Hay-Fever and Hay-Asthma

BMJ, 1884
openaire   +1 more source

HAI‐2 is epigenetically downregulated in human hepatocellular carcinoma, and its Kunitz domain type 1 is critical for anti‐invasive functions

International Journal of Cancer, 2009
Edmund Kwok-Kwan Tung, Chun-Ming Wong, Joyce Man-Fong Lee   +2 more
exaly  

Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer

Annals of Oncology, 2009
A Hongo, Junichi Kodama, Y Nasu
exaly  

Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer

Annals of Oncology, 2009
Nancy Kemény, M Capanu, Yuman Fong
exaly  

Trends in the occurrence of human and veterinary antibiotics in the sediments of the Yellow River, Hai River and Liao River in northern China

Environmental Pollution, 2011
Li-Jun Zhou, , Jian-Liang Zhao
exaly  

Aberrant regulation favours matriptase proteolysis in neoplastic B-cells that co-express HAI-2

Journal of Enzyme Inhibition and Medicinal Chemistry, 2019
Yi-Lin Chiu, Yi-Ying Wu, Yu-Wen Lin
exaly